GGSK Read More GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank saysSeptember 4, 2026 GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says Proactive uses images sourced from Shutterstock GSK…
GGSK Read More Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK?September 3, 2026 Moderna MRNA recently secured FDA approval for mFlusiva, the first mRNA-based seasonal flu vaccine. The decision is a…
GGSK Read More GSK hopes to take on Moderna as it moves mRNA flu vaccine to Phase III trialSeptember 2, 2026 GSK’s seasonal, mRNA-based influenza vaccine is progressing to a Phase III study after securing a safety and efficacy…
GGSK Read More GSK Advances mRNA Flu Shot to Phase 3 After Beating Standard Vaccines in Mid-Stage Trial — BigGo FinanceSeptember 2, 2026 GSK is moving its experimental mRNA-based seasonal flu vaccine into a late-stage trial after mid-stage data showed it…